| Literature DB >> 24867992 |
Matthew Metz1, David M Shlaes2.
Abstract
The fight against antibiotic resistance must be strengthened. We propose actions that U.S. government agencies and private sector entities can take to build a more comprehensive effort. These actions can increase the viability of investing in new antibiotics, ensure the quality and stewardship of all antibiotics, and make responses to emerging resistance more informed. Success requires the thoughtful exercise of federal authority and a firm commitment to share data and reward developers for the value generated with new, life-saving antibiotics.Mesh:
Substances:
Year: 2014 PMID: 24867992 PMCID: PMC4136015 DOI: 10.1128/AAC.02623-14
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191